Amneal Pharmaceuticals, Inc. (AMRX) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Amneal Pharmaceuticals, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | 54.80x | -20.94x | -12.65x | -2.31x | 67.14x | 7.49x |
| P/B Ratio | -55.77x | -22.40x | 53.70x | 1.01x | 1.98x | 2.25x |
| P/S Ratio | 1.31x | 0.88x | 0.44x | 0.14x | 0.34x | 0.34x |
| Profitability | ||||||
| Gross Margin | 37.6% | 36.5% | 36.1% | 35.8% | 36.7% | 31.5% |
| Operating Margin | 14.0% | 8.9% | 8.5% | -4.3% | 7.3% | 4.6% |
| Net Margin | 2.4% | -4.2% | -3.5% | -5.9% | 0.5% | 4.6% |
| EBITDA Margin | 20.0% | 15.7% | 20.9% | 19.9% | 19.2% | 17.3% |
| Liquidity | ||||||
| Current Ratio | 2.17x | 1.41x | 1.63x | 1.88x | 2.24x | 2.29x |
| Quick Ratio | 1.48x | 0.86x | 0.94x | 1.17x | 1.52x | 1.57x |
| Leverage | ||||||
| Debt/Equity | -38.65x | -23.73x | 139.05x | 9.53x | 7.98x | 9.89x |
YoY = year-over-year change. Source: FMP..